Learn More
5010 Background: Enzastaurin (E) is a potent, selective serine-threonine kinase inhibitor which suppresses tumor cell proliferation by targeting PKCβ and PI3/AKT pathways, inducing apoptosis and(More)
TPS118 Background: Pertuzumab (P) is a promising new anti-HER2 antibody which has shown both activity and good tolerability when combined with trastuzumab (H) in patients with HER2-positive breast(More)
  • 1